235 related articles for article (PubMed ID: 4404626)
1. A long-term pilot study of pipothiazine palmitate in chronic schizophrenia.
Villeneuve A; Pires A; Jus A; Lachance R; Drolet A
Curr Ther Res Clin Exp; 1972 Nov; 14(11):696-706. PubMed ID: 4404626
[No Abstract] [Full Text] [Related]
2. Pilot trials with long-acting pipotiazine injections.
Hakola A
Acta Psychiatr Scand Suppl; 1973; 241():31-42. PubMed ID: 4147509
[No Abstract] [Full Text] [Related]
3. Clinical experience with pipothiazine palmitate (19552 R.P.) in hospitalized and open ward patients with functional psychoses.
Salvesen C; Vaksdal K
Behav Neuropsychiatry; 1973 Oct-1974 Mar; 5(7-12):3-7. PubMed ID: 4154740
[No Abstract] [Full Text] [Related]
4. Uncontrolled study with pipothiazine palmitate.
Jain RC; Ananth JV; Klingner A; Ban TA; Lehmann HE
Int J Clin Pharmacol; 1973 Feb; 7(1):32-6. PubMed ID: 4699381
[No Abstract] [Full Text] [Related]
5. [Experiences with depot-neuroleptics in an after-care unit. Organization of the therapy exemplified with pipotiazine palmitate].
Salvesen C; Vaksdal K
Tidsskr Nor Laegeforen; 1973 Aug; 93(24):1699-703. PubMed ID: 4149082
[No Abstract] [Full Text] [Related]
6. Pipotiazine palmitate (19.552 R.P.) in the long-term treatment of chronic psychoses. A controlled trial on in-patients.
Robak OH
Acta Psychiatr Scand Suppl; 1973; 241():83-94. PubMed ID: 4147515
[No Abstract] [Full Text] [Related]
7. Dexetimide: an effective drug for the control of extrapyramidal symptoms induced by pipothiazine palmitate.
Dom R; Van Lommel R; Baro F
Acta Psychiatr Scand; 1973; 49(5):563-9. PubMed ID: 4148581
[No Abstract] [Full Text] [Related]
8. Monthly intermittent chemotherapy of chronic schizophrenic outpatients with pipothiazine palmitate.
Laurent JS; Carle R; Dumais B; Domingue D
Can Psychiatr Assoc J; 1974 Dec; 19(6):583-91. PubMed ID: 4155349
[No Abstract] [Full Text] [Related]
9. General evaluation of pipotiazine palmitate (19.552 R.P.) in hospitalized schizophrenic patients.
Gerlach J; Nyeborg O; Prieto R
Acta Psychiatr Scand Suppl; 1973; 241():69-74. PubMed ID: 4147513
[No Abstract] [Full Text] [Related]
10. A controlled one-year study of pipotiazine palmitate and fluphenazine decanoate in chronic schizophrenic syndromes. Evaluation of results at 6 and 12 months' trial.
Dencker SJ; Frankenberg K; Malm U; Zell B
Acta Psychiatr Scand Suppl; 1973; 241():101-18. PubMed ID: 4147508
[No Abstract] [Full Text] [Related]
11. Review of clinical trials with pipotiazine, pipotiazine undecylenate and pipotiazine palmitate.
Brown-Thomsen J
Acta Psychiatr Scand Suppl; 1973; 241():119-38. PubMed ID: 4151807
[No Abstract] [Full Text] [Related]
12. [Comparative study of delayed-action neuroleptics in psychiatric therapeutics].
Pellet J; Guyotat J; Marie-Cardine M; Dubor P; Favre-Tissot M; Caron F; Cottraux J
J Med Lyon; 1972 Apr; 53(227):591-8. PubMed ID: 4404295
[No Abstract] [Full Text] [Related]
13. Pipotiazine palmitate: an evaluation of a new long acting intramuscular antipsychotic agent in severely ill schizophrenic patients.
Gallant DM; Mielke D; Bishop G; Oelsner T; Guerrero-Figueroa R
Dis Nerv Syst; 1975 Apr; 36(4):193-6. PubMed ID: 1090427
[TBL] [Abstract][Full Text] [Related]
14. [Dynamics and treatment of the tendency to enchronization of schizophrenic psychoses].
López-Ibor Aliño JM
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1973; 1(2):377-88. PubMed ID: 4147379
[No Abstract] [Full Text] [Related]
15. Fluspirilene, a long-acting injectable neuroleptic.
Ciccarelli G; Nosé F; Zuanazzi GF
Acta Psychiatr Belg; 1972 Nov; 72(6):736-47. PubMed ID: 4679675
[No Abstract] [Full Text] [Related]
16. Potential value of penfluridol and pipothiazine palmitate.
Gallant DM
Psychopharmacol Bull; 1975 Jan; 11(1):11-2. PubMed ID: 235769
[No Abstract] [Full Text] [Related]
17. Clinical experience with pipotiazine palmitate (19.552 R.P.) in Nordic countries. Report of a multicentre investigation.
Kristjansen P; Dencker SJ; Elley J; Hakola A; Heshe J; Malm U; Robak OH; Salvesen C; Vaksdal K
Acta Psychiatr Scand Suppl; 1973; 241():51-6. PubMed ID: 4147511
[No Abstract] [Full Text] [Related]
18. Clinical evaluation of pipotiazine palmitate (19.552 R.P.) used on patients in an acute reception ward.
Elley JH; Petersen JH
Acta Psychiatr Scand Suppl; 1973; 241():75-82. PubMed ID: 4147514
[No Abstract] [Full Text] [Related]
19. [Pipothiazine (piportil) in the treatment of various forms of schizophrenia].
Matkowski K; Sep-Kowalikowa B
Psychiatr Pol; 1979; 13(4):421-3. PubMed ID: 42095
[No Abstract] [Full Text] [Related]
20. Conditioning in the prediction of drug withdrawal effects in chronic schizophrenic patients.
Ban TA; Ananth JV; Lehmann HE
Act Nerv Super (Praha); 1974 Mar; 16(1):23-33. PubMed ID: 4156144
[No Abstract] [Full Text] [Related]
[Next] [New Search]
